Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 15/5/2018
SIETES contiene 92334 citas

 
 
 1 a 20 de 1264 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Park Y, Hernandez-Diaz S, Bateman BT, Cohen JM, Desai RJ, Patorno E, Glynn RJ, Cohen LS, Mogun H, Huybrechts KF. Continuation of atypical antipsychotic medication during early pregnancy and the risk of gestational diabetes. Am J Psychiatry 2018:7 de mayo. [Ref.ID 102604]
2. Cita con resumen
Weintraub A. It's another dust-up over AstraZeneca's CEO pay, this time focused on his bonus. FiercePharma 2018:8 DE MAYO. [Ref.ID 102597]
3. Cita con resumen
Anónimo. Takeda reaches $62 billion deal to buy shire. DIA Daily 2018:1. [Ref.ID 102596]
4. Cita con resumen
Swetlitz I. Gottlieb pushes back against criticism of ‘breakthrough’ designation. STAT Daily Recap 2018:5. [Ref.ID 102595]
5.Enlace a cita original Cita con resumen
Webster P. Pimavanserin evaluated by the FDA. Lancet 2018;391:5 de mayo. [Ref.ID 102594]
6.Enlace a cita original Cita con resumen
Egan MF, Kost J, Tariot PN, Aisen PS, Cummings JL, Vellas B, Sur C, Mukai Y, Voss T, Furtek C, Mahoney E, Mozley LH, Vandenberghe R, Mo Y, Michelson D. Randomized trial of verubecestat for mild-to-moderate Alzheimer’s disease. N Engl J Med 2018;378:3 de mayo. [Ref.ID 102593]
7.Enlace a cita original Cita con resumen
The Dry Eye Assessment and Management Study Research Group. n-3 fatty acid supplementation for the treatment of dry eye disease. N Engl J Med 2018;378:3 de mayo. [Ref.ID 102592]
8.Enlace a cita original Cita con resumen
Kamali KN, Lloyd-Jones DM, van der Leeuw J, Goff Jr DC, Yusuf S, Zanchetti A, Glasziou P, Jackson R, Woodward M, Rodgers A, Neal BC, Berge E, Teo K, Davis BR, Chalmers J, Pepine C, Rahimi K, Sundström J, on behalf of the Blood Pressure Lowering Treatment Trialists’ Collaboration. Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data. PLOS Medicine 2018:20 de marzo. [Ref.ID 102591]
9.Enlace a cita original Cita con resumen
Gershon AS, Campitelli MA, Hawken S, Victor C, Sproule BA, Kurdyak P, Selby P. Cardiovascular and neuropsychiatric events after varenicline use for smoking cessation. Am J Respir Crit Care Med 2018;197:913-22. [Ref.ID 102579]
10.Enlace a cita original Cita con resumen
Okun MS. Demoralization in Parkinson disease. Journal Watch 2018:30 de abril. [Ref.ID 102578]
11.Enlace a cita originalTiene citas relacionadas Cita con resumen
Hopcroft K. Effectiveness of antidepressants - should we rethink treatment duration?. BMJ 2018;361:24 de abril. [Ref.ID 102576]
12.Enlace a cita original Cita con resumen
Baket T, Datta P, Rewers-Felkins K, Thompson H, Kallem RR, Hale TW. Transfer of inhaled cannabis into human breast milk. Obstet Gynecol 2018;131:783-8. [Ref.ID 102575]
13.Enlace a cita original Cita con resumen
Rabin JC, Karunathilake N, Patrizi K. Effects of milk vs dark chocolate consumption on visual acuity and contrast sensitivity within 2 hours. A randomized clinical trial. Jama Ophthalmol 2018:26 de abril. [Ref.ID 102572]
14.Enlace a cita original Cita con resumen
Richardson K, Fox C, Maidment I, Steel N, Loke YK, Arthur A, Myint PK, Grossi CM, Mattishent K, Bennett K, Campbell NL, Boustani M, Robinson L, Brayne C, Matthews FE, Savva GM. Anticholinergic drugs and risk of dementia: case-control study. BMJ 2018;361:25 de abril. [Ref.ID 102571]
16.Enlace a cita original Cita con resumen
Peter I, Dubinsky M, Bressman S, Park A, Lu C, Chen N, Wang A. Anti–tumor necrosis factor therapy and incidence of Parkinson disease among patients with inflammatory bowel disease. JAMA Neurology 2018:23 de abril. [Ref.ID 102569]
17.Enlace a cita originalTiene citas relacionadas Cita con resumen
Mitjà O, Godornes C, Houinei W, Kapa A, Paru R, Abel H, González-Beiras C, Bieb SV, Wangi J, Barry AE, Sanz S, Bassat Q, Lukehart SA. Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: a longitudinal study. Lancet 2018;391:21 de abril. [Ref.ID 102568]
18.Enlace a cita originalTiene citas relacionadas Cita con resumen
Šmajs D, Pospíšilová P. Macrolide resistance in yaws. Lancet 2018;391:21 de abril. [Ref.ID 102567]
19.Enlace a cita original Cita con resumen
Bergman JEH, Lutke LR, Gans ROB, Addor M-C, Barisic I, Clavero-Carbonell C, Garne E, Gatt M, Klungsoyr K, Lelong N, Lynch C, Mokoroa O, Nelen V, Neville AJ, Pierini A, Randrianaivo H, Rißmann A, Tucker D, Wiesel A, Dolk H, Loane M, Bakker MK. Beta-blocker use in pregnancy and risk of specific congenital anomalies: A European case-malformed control study. Drug Saf 2018;41:415-27. [Ref.ID 102566]
20.Enlace a cita original Cita con resumen
Golomb BA, Verden A, Messner AK, Koslik HJ, Hoffman KB. Amyotrophic lateral sclerosis associated with statin use: a disproportionality analysis of the FDA's adverse event reporting system. Drug Saf 2018;41:abril. [Ref.ID 102565]
Seleccionar todas
 
 1 a 20 de 1264 siguiente >>